🧩 Step 5 — Concept Integration

🧭 Whole Topic Core Flow

Whole Topic Core Flow

Glucose Intake
↓
GLUT Transporters move glucose into cells
↓
Glycolysis in cytoplasm produces ATP + pyruvate
↓
NADH shuttles transfer reducing power into mitochondria
↓
Pyruvate enters mitochondria via PDH complex
↓
Acetyl-CoA enters TCA cycle → oxidative phosphorylation → major ATP production
↓
Liver maintains blood glucose through gluconeogenesis during fasting
↓
Hormonal regulation balances glycolysis and gluconeogenesis
(Insulin → glycolysis ↑ ; Glucagon → gluconeogenesis ↑)

Functional Failure Integration

GLUT dysfunction / insulin resistance
↓
Reduced glucose uptake
↓
Hyperglycemia + reduced cellular ATP
↓
Increased gluconeogenesis in liver
↓
Diabetes mellitus metabolic imbalance

Anaerobic Failure Integration

Low oxygen / mitochondrial dysfunction
↓
Pyruvate cannot enter TCA cycle
↓
Pyruvate converts to lactate
↓
Lactic acidosis
↓
Cellular dysfunction

Enzyme Defect Integration

Pyruvate kinase deficiency
↓
Reduced ATP in RBC
↓
Membrane pump failure
↓
Hemolytic anemia

PDH Failure Integration

PDH deficiency / thiamine deficiency
↓
Reduced acetyl-CoA formation
↓
Reduced aerobic ATP production
↓
Pyruvate accumulation → lactate formation
↓
Neurological dysfunction + lactic acidosis

Drug Integration

Insulin therapy
↓
GLUT-4 activation
↓
Increased glucose uptake + glycolysis
↓
Reduced blood glucose

Metformin
↓
Suppresses hepatic gluconeogenesis
↓
Reduced glucose output from liver
↓
Improved glycemic control

1️⃣ Master Integration Chain

Paste your master integration chain here.

2️⃣ Core Mechanism Integration

Main Physiological Failure Mechanism

Reduced Aerobic Glucose Metabolism
↓
Failure of pyruvate entry into mitochondria
(PDH defect / hypoxia / thiamine deficiency)
↓
Reduced acetyl-CoA production
↓
Reduced TCA cycle activity
↓
Reduced oxidative phosphorylation
↓
Reduced ATP generation
↓
Cells shift toward anaerobic glycolysis
↓
Excess lactate formation
↓
Lactic acidosis
↓
Neurological dysfunction + muscle weakness + cellular injury

🩺 Clinical Integration Snapshot

Flow 1 — Pyruvate Kinase Deficiency

Pyruvate kinase deficiency
↓
Reduced ATP generation in RBC
↓
Failure of Na⁺/K⁺ membrane pumps
↓
Rigid RBC membrane
↓
Hemolysis
↓
Hemolytic anemia
↓
Supportive transfusion ± splenectomy

Flow 2 — PDH Deficiency

PDH enzyme defect
↓
Pyruvate cannot convert into acetyl-CoA
↓
Excess pyruvate converted to lactate
↓
Lactic acidosis
↓
Brain energy deficiency
↓
Developmental delay + neurological symptoms
↓
Ketogenic diet + thiamine supplementation

Flow 3 — Diabetes Mellitus Integration

Insulin deficiency / resistance
↓
Reduced GLUT-4 mediated glucose uptake
↓
Reduced glycolysis in muscle and adipose tissue
↓
Increased hepatic gluconeogenesis
↓
Persistent hyperglycemia
↓
Polyuria + dehydration + fatigue
↓
Insulin / metformin therapy

⚡ Ultra-High-Yield Master Summary

Glucose enters cells through GLUT transporters
↓
Glycolysis produces pyruvate + small ATP
↓
PDH converts pyruvate → acetyl-CoA
↓
TCA cycle + oxidative phosphorylation produce major ATP
↓
During fasting, liver performs gluconeogenesis to maintain blood glucose

Disease Mechanism

Enzyme defect / hypoxia / insulin resistance
↓
Reduced aerobic glucose utilization
↓
Lactate accumulation or hyperglycemia
↓
Cellular dysfunction

Drug Action

Insulin → glycolysis ↑ + glucose uptake ↑
Metformin → gluconeogenesis ↓
Thiamine → supports PDH activity

Treatment Effect

Improved ATP production
↓
Reduced lactate / blood glucose
↓
Restored metabolic balance